ETOPOPHOS Drug Patent Profile
✉ Email this page to a colleague
When do Etopophos patents expire, and when can generic versions of Etopophos launch?
Etopophos is a drug marketed by Bristol Myers Squibb and Cheplapharm and is included in two NDAs.
The generic ingredient in ETOPOPHOS is etoposide phosphate. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etoposide phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ETOPOPHOS?
- What are the global sales for ETOPOPHOS?
- What is Average Wholesale Price for ETOPOPHOS?
Summary for ETOPOPHOS
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for ETOPOPHOS |
| What excipients (inactive ingredients) are in ETOPOPHOS? | ETOPOPHOS excipients list |
| DailyMed Link: | ETOPOPHOS at DailyMed |
US Patents and Regulatory Information for ETOPOPHOS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-002 | Feb 27, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-001 | Feb 27, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cheplapharm | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020457-001 | May 17, 1996 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
